CARAVAGGIO Expands DOAC Pool in Cancer-related VTE

Randomized but open-label data show apixaban was noninferior to dalteparin for efficacy but with less major bleeding, including problematic GI bleeds.
Medscape Medical News

Source link

Related posts

Coronavirus and Parkinson’s disease


Reducing Accidental Needlesticks During Intraoperative Neuromonitoring


Making a ‘JUMP’ from paediatric to adult healthcare: A transitional program for young adults with chronic neurological disease


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy